Paclitaxel-induced modification of the effects of radiation and alterations in the cell cycle in normal and tumor mammalian cells

Radiation Research

Volumn 150, Issue 3, 1998, Pages 283-291

  Gorodetsky, Raphael ^a   Levdansky, Lilia ^a   Ringel, Israel ^b   Vexler, Akiva ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CELL SYNCHRONIZATION; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; SKIN FIBROBLAST;

MAMMALIA;

EID: 0031657209     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579977     Document Type: Article

References (56)

1. J. J. Manfredi and S. B. Horwitz, Taxol: An antimitotic agent with a new mechanism of action. Pharmacol. Ther. 25, 83-125 (1984).
2. S. B. Horwitz, L. Lothstein, J. J. Manfredi, W. Mellado, J. Parness, S. N. Roy, P. B. Schiff, L. Sorbana and R. Zeheb, Taxol: Mechanism of action and resistance. Ann. NY Acad. Sci. 466, 733-744 (1986).
3. E. K. Rowinsky, L. A. Cazenave and R. C. Donehower, Taxol: A novel investigational antimicrotubule agent. J. Natl. Cancer Inst. 82, 1247-1259 (1990).
4. W. J. Slichenmyer and D. D. von Hoff, Taxol: A new and effective anti-cancer drug. Anti-Cancer Drugs 2, 519-530 (1991).
5. E. K. Rowinsky, N. Onnetto, R. M. Canneta and S. G. Arbuck, Taxol: The first of the taxanes, an important new class of antitumor agents. Semin. Oncol. 19, 646-662 (1992).
6. W. C. Rose, Taxol: A review of its preclinical in vivo antitumor activity. Anti-Cancer Drugs 3, 311-321 (1992).
7. R. S. Gupta, Species-specific differences in toxicity of antimitotic agents toward cultured mammalian cells. J. Natl. Cancer Inst. 74, 159-164 (1985).
8. M. N. Jordan, R. J. Toso, D. Thrower and L. Wilson, Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl. Acad. Sci. USA 90, 9552-9556 (1993).
9. J. E. Liebmann, J. A. Cook, C. Lipschultz, D. Teague, J. Fisher and J. B. Mitchell, The influence of cremophor EL on the cell cycle effects of paclitaxel (taxol) in human tumor cell lines. Cancer Chemother. Pharmacol. 33, 331-339 (1993).
10. J. E. Liebmann, J. A. Cook, C. Lipschultz, D. Teague, J. Fisher and J. B. Mitchell, Cytotoxic studies of paclitaxel (taxol) in human tumor cell lines. Br. J. Cancer 68, 1104-1109 (1993).
11. N. M. Lopes, E. G. Adams, T. W. Pitts and B. K. Bhuyan, Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother. Pharmacol. 32, 235-242 (1993).
12. J. S. Stromberg, Y. J. Lee, E. P. Armour, A. A. Martinez and P. M. Corry, Lack of radiosensitization after paclitaxel treatment of three human carcinoma lines. Cancer 75, 2262-2268 (1995).
13. C. Hennequin, N. Giocanti and V. Favaudon, S-phase specificity of cell killing by docetaxel (taxotere) in synchronised HeLa cells. Br. J. Cancer 71, 1194-1198 (1995).
14. K. L. Donaldson, G. L. Goolsby and A. F. Wahl, Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int. J. Cancer 57, 847-855 (1994).
15. R. B. Tishler, C. R. Geard, E. J. Hall and P. B. Schiff, Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52, 3495-3497 (1992).
16. R. B. Tishler, P. B. Schiff, C. R. Geard and E. J. Hall, Taxol: A novel radiation sensitizer. Int. J. Radiat. Oncol. Biol. Phys. 22, 613-617 (1992).
17. H. Choy, F. F. Rodriguez, S. Koester, S. Hilsenbeck and D. D. von Hoff, Investigations of taxol as a potential radiation sensitizer. Cancer 71, 3774-3778 (1993).
18. A. J. Steren, B. U. Sevin, J. Perras, R. Angioli, H. N. Nguyen, L. Guerra, O. R. Koechli and H. E. Averette, Taxol sensitizes human ovarian cancer cells to radiation. Gynecol. Oncol. 48, 252-258 (1993).
19. A. J. Steren, B. U. Sevin, J. Perras, R. Angioli, H. N. Nguyen, L. Guerra, O. R. Koechli and H. E. Averette, Taxol as a radiation sensitizer: A flow cytometric study. Gynecol. Oncol. 50, 89-93 (1993).
20. C. R. Geard and J. M. Jones, Radiation and taxol effects on synchronized human cervical carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 29, 565-569 (1994).
21. N. B. Hornback, R. N. Shen, G. P. Sutton, H. Shidnia and H. E. Kaiser, Synergistic cytotoxic and antitumor effects of irradiation and taxol on human HeLa cervix carcinoma and mouse B16 melanoma cells. In Vivo 8, 819-823 (1994).
22. J. E. Liebmann, J. A. Cook, D. Teague, J. Fisher, D. Coffin, W. De Graff, J. Gamson and J. B. Mitchell, Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (taxol). Int. J. Radiat. Oncol. Biol. Phys. 29, 559-564 (1994).
23. J. E. Liebmann, J. A. Cook, J. Fisher, D. Teague and J. B. Mitchell, In-vitro studies on taxol as a radiation sensitizer in human tumor cells. J. Natl. Cancer Inst. 86, 441-446 (1994).
24. B. L. Lokeshwar, S. M. Ferrell and N. L. Block, Enhancement of radiation response of prostatic carcinoma by taxol: Therapeutic potential for late stage malignancy. Anticancer Res. 15, 93-98 (1995).
25. F. Rodriguez, B. U. Sevin, J. Perras, H. N. Nguyen, C. Pham, A. J. Steren, O. R. Koechli and H. E. Averette, Paclitaxel: A radiation sensitizer of human cervical cancer cells. Gynecol. Oncol. 57, 165-169 (1995).
26. P. A. Mote, M. W. Davey, R. A. Davey and L. Oliver, Paclitaxel sensitizes multidrug resistant cells to radiation. Anti-Cancer Drugs 7, 182-188 (1996).
27. E. J. Hall, L. Minarik, T. K. Hei and P. B. Schiff, Taxol and radiation: Studies in cooperative cytotoxicity using cells cultured in vitro. Int. J. Radiat. Oncol. Biol. Phys. 24 (Suppl. 1), 273-274 (1992). [Abstract]
28. C. R. Geard, J. M. Jones and P. B. Schiff, Taxol and radiation. Natl. Cancer Inst. Monogr. 15, 89-94 (1993).
29. T. K. Hei and E. J. Hall, Taxol, radiation and oncogenic transformation. Cancer Res. 53, 1368-1372 (1993).
30. T. K. Hei, C. P. Piao, C. R. Geard and E. J. Hall, Taxol and ionizing radiation: Interaction and mechanisms. Int. J. Radiat. Oncol. Biol. Phys. 29, 267-271 (1994).
31. L. Minarik and E. J. Hall, Taxol in combination with acute and low dose rate irradiation. Radiother. Oncol. 32, 124-128 (1994).
32. C. Hennequin, N. Giocanti and V. Favaudon, Interaction of ionizing radiation with paclitaxel (taxol) and docetaxel (taxotere) in HeLa and SQ20B cells. Cancer Res. 56, 1842-1850 (1996).
33. J. Liebmann, L. Herscher, J. Fisher, D. Teague and J. A. Cook, Antagonism of paclitaxel cytotoxicity by X-rays: Implications for the sequence of combined modality therapy. Clinical study. Int. J. Oncol. 8, 991-996 (1996).
34. H. Arioka and N. Saijo, Microtubules and antineoplastic drugs. Can. To. Kagaku Ryoho 21, 583-590 (1994).
35. L. Milas, N. R. Hunter, K. A. Mason, B. Kurdoglu and L. J. Peters, Enhancement of tumor radioresponse of murine mammary carcinoma by paclitaxel. Cancer Res. 54, 3506-3510 (1994).
36. K. A. Mason, L. Milas and L. J. Peters, Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa. Int. J. Radiat. Oncol. Biol. Phys. 32, 1381-1389 (1995).
37. L. Milas, N. R. Hunter, K. A. Mason, C. G. Milross, Y. Saito and L. J. Peters, Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res. 55, 3564-3568 (1995).
38. D. I. Rosenthal and D. P. Carbone, Taxol plus radiation for head and neck cancer. J. Infus. Chemother. 5, 46-54 (1995).
39. - cotransport by different mitogens in synchronized human skin fibroblasts is essential for cell proliferation. J. Cell Biol. 114, 337-342 (1991).
40. A. T. Horowitz, A. J. Treves, R. Voss, E. Okon, Z. Fuks, L. Davidson and S. Biran, A new human carcinoma cell line: Establishment and analysis of tumor associated markers. Oncology 42, 332-337 (1985).
41. S. Rockwell, Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT-6 mouse mammary tumor cells in vivo and in vitro. Br. J. Cancer 37, 212-215 (1978).
42. A. M. Vexler, X. Mou, A. Gabizon and R. Gorodetsky, Reduction of the systemic toxicity of cisplatin by intra-arteial hepatic route administration for liver malignancies. Int. J. Cancer 60, 611-615 (1995).
43. D. A. Scudiero, R. H. Shoemaker, K. D. Paul, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff and M. R. Boyd, Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48, 4827-4833 (1988).
44. R. Gorodetsky, X. Mou, M. R. Pfeffer, T. Peretz, F. Levy-Agababa and A. M. Vexler, Sub-additive effect of the combination of radiation and cisplatin in cultured murine and human cell lines. Isr. J. Med. Sci. 31, 95-100 (1995).
45. F. Zolzer, C. Streffer and T. Peltzer, Induction of quiescent S-phase cells by irradiation and/or hyperthermia. I. Time and dose dependence. Int. J. Radiat. Biol. 63, 69-76 (1993).
46. F. Zolzer, C. Streffer and T. Peltzer, Induction of quiescent S-phase cells by irradiation and/or hyperthermia. II. Correlation with colony forming ability. Int. J. Radiat. Biol. 63, 77-82 (1993).
47. K. L. Donaldson, G. L. Goolsby, P. A. Kiener and A. F. Wahl, Activation of p34cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ. 5, 1041-1050 (1994).
48. L. Milas, N. R. Hunter, B. Kurdoglu, K. A. Mason, R. E. Meyn, L. C. Stephens and L. J. Peters, Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol. 35, 297-303 (1995).
49. C. M. Woods, J. Zhu, P. A. McQueney, D. Bollag and E. Lazarides, Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1, 506-526 (1995).
50. 2/M arrest and apoptosis. Nat. Med. 2, 72-79 (1996).
51. M. V. Blagosklonny, P. Giannakakou, W. S. el-Deiry, D. G. Kingston, P. I. Higgs, L. Neckers and T. Fojo, Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death. Cancer Res. 57, 130-135 (1997).
52. L. Milas, N. R. Hunter, K. A. Mason, C. G. Milross and L. J. Peters, Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. Acta Oncol. 34, 409-412 (1995).
53. R. L. Ball, D. H. Carney and T. Albrecht, Taxol inhibits stimulation of cell DNA synthesis by human cytomegalovirus. Exp. Cell Res. 191, 37-44 (1990).
54. R. M. Gubits, C. R. Geard and P. B. Schiff, Expression of immediate early-genes after treatment of human astrocytoma cells with radiation and taxol. Int. J. Radiat. Oncol. Biol. Phys. 27, 637-642 (1993).
55. W. K. Sinclair and R. A. Morton, X-ray sensitivity during cell of cultured Chinese hamster cells. Radiat. Res. 29, 450-474 (1969).
56. F. B. Vexler, L. N. Kublik, L. Kh. Eidus and A. M. Vexler, Kinetics of repair of DNA single-strand breaks in cultured mammalian cells. Part I. The dependence on irradiation dose and cell cycle stage. Int. J. Radiat. Biol. 41, 453-457 (1982).